Frontlight ResearchEarly access
Trial site
Korea University Ansan Hospital
- 4running trials
- 6closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis3 trials
- Atopic dermatitis (eczema)1 trial
- Chronic kidney disease1 trial
- Chronic spontaneous urticaria1 trial
- Crohn's disease1 trial
- Depression1 trial
- Familial hypercholesterolaemia1 trial
- High blood pressure1 trial
- Primary biliary cholangitis1 trial
- Stroke1 trial
- Phase
- Phase 34 trials
- Phase 22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed5 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Yuhan Corporation2 trials
- Asan Medical Center1 trial
- Curacle Co., Ltd.1 trial
- Eli Lilly and Company1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic spontaneous urticaria1 recruiting
- Stroke1 recruiting
Closed trials
Recruiting
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026